Introduction
Integrins are transmembrane protein receptors that mediate cell-matrix and cell-cell adhesion. They consist of non-covalently linked heterodimers, which are composed of alpha (α) and beta (β) subunits (1) . To date, 18 α and 8 β subunits have been characterized and shown to assemble into at least 24 distinct integrin heterodimers in humans (1, 2) . Integrins link their extracellular ligands to intracellular focal adhesion complexes and cytoskeletal elements and function as dynamic, bidirectional signaling receptors (3) . Cells often express more than one type of integrin complex, which can exist in either an active or inactive conformational state (4) . Changes in the expression of different types of integrins provide a cell with a mechanism by which it can interact with and respond to the unique extracellular matrix (ECM) in its immediate environment (5) . Since integrin function is critical for a variety of cellular processes, the variables mentioned above allow for a wide range of responses related to cell adhesion, motility, proliferation, differentiation, and morphogenesis (1) .
The various α/β integrin heterodimers can be clustered into four families based on their ligand-binding characteristics (2) . Members of the Leu-Asp-Val (LDV)-binding integrin family (α4β1, α4β7, α9β1, αEβ7, and the four members of the β2 subfamily) recognize a structurally related acid motif sequence in their ligands. The β2 integrin subfamily consists of the β2 subunit (also termed CD18) in combination with one of four different α (CD11) subunits: αL (CD11a), αM (CD11b), αX (CD11c), or αD (CD11d). β2 integrins and their ligands, consisting of various ECM proteins and immunoglobulin-type counter-receptors such as the intercellular adhesion molecules, have been intensely studied in circulating leukocytes and play an important role Correspondence: G.T. Kitten, Departamento de Morfologia, ICB, UFMG, 30270-901 Belo Horizonte, MG, Brasil. USA efax: +815-377-0222. E-mail: kitten@icb.ufmg.br in the immune-inflammatory response (6) . β2 integrin is essential for leukocyte binding to and transmigration through the endothelial cell layer (7) . Leukocytes from genetically engineered mice, which lack β2 integrin, do not adhere or transmigrate efficiently through the endothelium at sites of injury (8) . Mutation or deletion of specific sites within either the extracellular or the cytoplasmic domains of β2 integrin also leads to reduced levels of β2 integrin expression and function (9) . Similar deficiencies are observed in patients suffering from leukocyte adhesion deficiency-1 in which neutrophils displaying low levels of β2 integrin expression fail to arrive at sites of injury (7) .
Although β2 integrin is often described as a "leukocytespecific integrin", or as being "expressed exclusively in hematopoietic cells" (10) , and has been mainly studied in relation to its role during leukocyte adhesion and inflammatory responses (6), a few studies have shown that it is also expressed by other cell types such as human umbilical vein endothelial cells (HUVEC) (11) , cancer cells (12) and bone marrow stromal stem cells (13) . However, little is known about the function of β2 integrin outside of its leukocyte-associated activities. While there have been numerous studies on integrins β1 and β3 and their associated alpha subunits in various tissues during development (5, 14) , there have been very few studies addressing the expression or function of β2 integrin during embryonic development. Chamoux et al. (15) described the specific expression of the β2 integrin subunit in chromaffin cells during development of the fetal adrenal gland. These investigators postulated that β2 integrin may play a role in the migration of neural crest-derived pheochromoblasts through the fetal adrenal cortex to the center of the gland, where they colonize and are important in the formation of the chromaffin cells within the adrenal medulla. A study in Xenopus embryos, in which the timing of appearance of various beta integrins was analyzed, noted that β2 integrin was expressed at high levels in late tailbud stages, but its distribution was not determined (16) .
Integrin-mediated cellular interactions are essential during embryogenesis, including cardiac morphogenesis (17) (18) (19) . During the initial stages of cardiac development, the embryonic heart tube is composed of three layers: the external myocardium, the internal endothelial layer and the cardiac jelly, an acellular layer containing various types of ECM proteins (20) (21) (22) . As development proceeds, the cardiac jelly expands to form endocardial cushions in the atrioventricular (AV) canal and outflow tract. Within the endocardial cushions, signals originating from the myocardium activate a subset of endothelial cells to undergo an epithelial-mesenchymal transformation (EMT) and migrate into the cardiac jelly (23) . These mesenchymal cells acquire fibroblast-like characteristics and are responsible for synthesizing most of the connective tissue proteins in the valve leaflets and membranous portion of the interventricular septum (21) .
Among the most common types of congenital heart defects are atrioventricular septal defects (AVSDs). Nearly 70% of all AVSDs are diagnosed in infants with trisomy 21 (Down syndrome) (24) . This association has led to speculation that genes on chromosome 21 are important in AV valve development. Interestingly, the β2 integrin gene locus has been mapped to the region on human chromosome 21, which has been linked to congenital heart defects (24), raising the possibility that it may play a role in AV valve morphogenesis. Therefore, the objective of the present study was to define the temporal and spatial distribution of β2 integrin in the developing embryonic heart during cardiac morphogenesis. Results from PCR, in situ hybridization and immunolocalization studies have demonstrated that β2 integrin and several of its α integrin partners are expressed by endothelial, mesenchymal, epicardial, and myocardial cells in both mouse and chicken embryonic hearts. These results indicate that β2 integrin can be expressed by non-hematopoietic embryonic cells where it may mediate various morphogenetic events such as those which occur during cardiogenesis.
Material and Methods

Embryos
Swiss mice were allowed to mate and pregnancy was detected by the presence of a copulation plug. The appearance of the plug was designated as day 0.5 of gestation. Embryos were dissected from the pregnant females after the required period of gestation. Fertilized White Leghorn eggs were incubated at 38°C and the chicken embryos were collected at stages HH10 to HH28 (25) . All protocols involving animals were reviewed and approved by the Ethics Committee for Animal Experimentation (CETEA) of the Federal University of Minas Gerais.
Immunostaining and confocal microscopy
Staged mouse embryos were dissected in phosphatebuffered saline (PBS), cryofixed and freeze-substituted in a -70°C solution of 80% methanol/20% dimethyl sulfoxide and then processed for cryostat sections. As a positive integrin beta control, the thymus from a 1-month-old mouse was collected and processed as above. Tissue sections were mounted on silane-coated slides and hydrated in dH 2 O followed by PBS. Nonspecific binding of antibodies was blocked using 1% bovine serum albumin (BSA), 0.1% Tween 20 in PBS for 1-2 h and followed by an overnight incubation at 4°C with primary antibodies. Affinity-purified polyclonal antibodies against specific integrin subunits were obtained from Santa Cruz Biotechnology, Inc. (USA): two different antibodies against β2 integrin were used (sc-6623, epitope at the C-terminus and sc-6625, epitope at the N-terminus), as well as αL (sc-15327), αM (sc-6614) and αX (sc-26692). FITC-conjugated rabbit anti-goat IgG (Cappel Laboratories, USA), Cy3-conjugated donkey anti- goat, Cy3-conjugated goat anti-rabbit and Cy5-conjugated donkey anti-goat (Jackson Laboratory, USA) were used as secondary antibodies. Primary and secondary antibodies were diluted in 0.1% BSA/0.01% Tween 20/PBS. After labeling with secondary antibodies for 1-2 h at room temperature, sections were washed in PBS and mounted in 10% 1.0 M Tris-HCl, pH 9.0/90% glycerol. In control experiments, primary antibodies were omitted from the staining protocol. Sections were analyzed using a laser scanning confocal microscope (Zeiss 510META, Germany).
We used fluorescent and hybrid routing protocols (HRP) to immunolocalize β2 integrin in embryonic chicken hearts. Immunofluorescent staining methods for β1 and β2 integrins were the same as used for mouse tissues. For HRP experiments, staged chicken embryos were dissected in PBS, fixed in 4% paraformaldehyde, paraffin embedded and sectioned. Sections were deparaffinized and hydrated and antigen retrieval was performed using 0.1 M citrate buffer, pH 5.5, for 15 min in a microwave oven. Endogenous peroxidase activity was blocked by immersing slides in 3% hydrogen peroxide in methanol. Slides were blocked with 2% BSA, 0.1% Tween 20 in PBS and incubated with polyclonal antibodies against β2 integrin (Santa Cruz Biotechnology, Inc., sc-6623 and sc-6625) as described above. Antibodies were diluted in 0.2% BSA, 0.01% Tween 20 in PBS. Sections were washed in PBS, incubated with HRP-conjugated secondary antibody at room temperature (Santa Cruz Biotechnology, Inc., sc-2020), and then washed again in PBS. Color reaction was carried out in the dark with 0.01% diaminobenzidine tetrahydrochloride and 0.03% H 2 O 2 in PBS. In control experiments, primary antibodies were omitted from the staining protocol. Images were captured using a Leica microscope (Germany) equipped with Normarski Optics.
Reverse transcriptase PCR (RT-PCR) and quantitative real-time PCR
Total RNA was extracted from White Leghorn chicken embryonic tissues using Trizol (Gibco, USA). For PCR expression studies, whole hearts and AV canal regions were microdissected from stage HH14-28 embryos. All samples were DNase treated (Ambion, USA) prior to reverse transcription using the iScript cDNA synthesis kit (Bio-Rad, USA). Samples were analyzed in a Nanodrop ND-100 analyzer (Thermo Fisher Scientific Inc., USA) and 1 µg template was added per PCR assay following the manufacturer's instruction. cDNA was synthesized using Hot Start PCR with AmpliTaq Gold DNA polymerase (Applied Biosystems, USA). cDNA concentration was established with the QuantiiT Oligreen ssDNA reagent (Molecular Probes, USA) as described previously (26) . Real-time PCR was performed with Platinum SYBR Green UDG (Invitrogen, USA) using 100 ng cDNA per reaction under the following conditions: 50°C for 2 min, 95°C for 2 min, and 35 cycles as follows: 94°C for 30 s, 58°C for 15 s, and 72°C for 45 s. A minimum of 3 different samples per stage were used and experiments were performed in triplicate for each sample. Primer pairs for each integrin subunit were designed using SciTools PrimerQuest (http://www.idtdna.com/Scitools/Applications/ Primerquest) and obtained commercially (Integrated DNA Technologies, USA). In order to avoid false results due to genomic DNA contamination, primers were designed to cross intron/exon boundaries. Separate forward and reverse primers for β2 integrin were used in RT-PCR and real-time PCR experiments. RT-PCR conditions were 95°C for 10 min and 35 cycles as follows: 94°C for 30 s, 60°C for 30 s, and 72°C for 45 s. Control reactions for RT-PCR and real-time PCR were performed using primers for the 18s ribosomal subunit. No-template control reactions were performed in every experiment. Additional controls, no enzyme and no primer, were also run in initial experiments (Table 1) .
In situ hybridization
Sense and antisense avian β2 integrin riboprobes corresponding to 387-1120 bp (GenBank NM_205251) were produced by RT-PCR from stage HH20 AV canal and subsequently cloned into pBlueScript II KS+ (Stratagene, USA). Sense (control) probe reactions were included in each experiment to determine the level of non-specific binding.
Whole-mount embryo in situ hybridization protocols Table 1 . List of real-time PCR and RT-PCR primers.
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For in situ hybridization analysis on tissue sections, staged chicken embryos were collected in PBS, fixed overnight in a 6:3:1 mixture of ethanol/formalin/acetic acid, embedded in paraffin and sectioned. Sections were de-waxed, hydrated, proteinase K treated (20 µg/ml) and then post-fixed in 4% paraformaldehyde in PBS. Sections were incubated in pre-hybridization solution at 65°C prior to overnight incubation with hybridization solution containing a riboprobe at 65°C. Slides were washed in SSC/50% formamide/0.1% Tween 20 at 65°C, blocked in 20% sheep serum/MABT/2% blocking powder at room temperature and then incubated overnight with anti-digoxigenin antibody diluted in the same blocking solution at 4°C. Slides were washed in MABT at room temperature and once in NTMT buffer prior to color reaction with NBT (Roche, USA) and BCIP (Roche) in NTMT at 37°C. Images were captured using a Leica microscope equipped with Normarski Optics.
Results β2 integrin expression in the developing mouse heart
mRNA transcripts of β2 integrin, as well as its α partners -αL, αM, and αX integrins -were successfully amplified by RT-PCR using RNA extracted from embryonic day 13.5 (ED13.5) whole hearts (Figure 1) . These results demonstrate that β2 integrin mRNA is present in the embryonic heart, but do not rule out the possibility that it was derived from a small number of hematopoietic cells, which remain in the lumen of the hearts after the collection and washing procedures.
In order to determine which cells actually express β2 integrin, we performed immunohistochemical localization experiments with two antibodies directed against different domains in β2 integrin (i.e., N-or C-terminal epitopes). Positive control sections of 1-month-old mouse thymus incubated with either of these antibodies showed strong immunolabeling of thymocytes ( Figure 2H ) as compared to secondary antibody control sections in which primary antibodies had been omitted from the incubation procedure ( Figure 2H , inset). β2 integrin immunolabeling was performed in mouse embryos obtained from stages ED10.5 to 19.5. At ED10.5 and ED11.5, β2 integrin immunostaining was observed in the endothelial layer of the cushions, on the surface of mesenchymal cells within the cardiac jelly, and in the epicardium (Figure 2A,B) . At ED10, the epicardial layer had not yet completed its migration and covered the external surface of the myocardium. A low level of staining was also observed in some areas of the myocardium.
At ED13.5, when active mesenchymal cell migration is still occurring in the cushions, a strong signal was observed in the endothelium and mesenchymal cells ( Figure 2C ). At ED15.5, β2 integrin signal decreased, but was still present in the valve endothelial cells and in mesenchymal cells, which were differentiating into the fibroblast-like, interstitial cells of the valve leaflets ( Figure 2D) . A similar pattern of β2 integrin expression continued to be seen during AV valve maturation at ED17.5 ( Figure 2E ) but became weaker in valve endothelial cells and fibroblasts of the prenatal mouse AV valve at ED19.5 ( Figure 2F ). At ED15.5, the epicardium was strongly labeled and positive myocardial cells were observed in both the mural and trabecular portions of the myocardium ( Figure 2G ). These observations show that β2 integrin is expressed by non-hematopoietic cells during the early stages of mouse heart development, including in cells involved in the EMT, which occurs in the forming valves. Occasionally, intensely immunolabeled cells were seen within the lumen of the heart ( Figure 2D-F) , with specific staining well above background autofluorescence, indicating high levels of β2 integrin expression. Although we have not characterized these cells, it is possible that they are hematopoietic cells, hemangioblasts, and/or endothelial progenitor cells, all of which are known to express β2 integrin (28) .
Immunolocalization of the α integrin partners of β2 integrin in embryonic mouse heart
As described above, mRNA transcripts for αL, αM, and αX were shown to be present in the embryonic heart (see Figure 1) . Immunohistochemical procedures using antibodies specific for these α integrin subunits allowed us to determine more precisely their distribution pattern. Endothelial cells of the AV canal cushion, mesenchymal cells inside the cardiac jelly and myocardial cells expressed αL integrin at ED11.5, during the initial stages of EMT ( Figure 3A ) and at ED13.5 ( Figure 3B ). Immunolabeling for αM integrin displayed the same pattern as observed for αL integrin in the AV canal at ED11.5 and ED13.5 ( Figure  3C,D ). An antibody specific for αX integrin showed that it was also expressed in the AV canal at ED11.5 and ED13.5
( Figure 3E ,F), but with slightly less reactivity in the myocardial layer. The positive results obtained with antibodies against the αL, αM and αX partners of β2 integrin indicate that various α/β2 integrin heterodimers are present in the embryonic heart.
β2 integrin expression in developing avian embryos
The distribution of β2 integrin was not unique to mouse heart since we also confirmed expression in embryonic chicken heart. RNA from whole hearts and AV canal seg- ments isolated a) at the onset of the EMT (HH14), b) during active mesenchymal cell invasion (HH17-HH20), and c) during endocardial cushion remodeling (HH25 and HH28) were used as templates for RT-PCR and real-time PCR. β2 integrin transcripts were expressed in all embryonic chick hearts and AV canal samples analyzed with RT-PCR ( Figure  4A,B) . Results of RT-PCR experiments using the 18s ribosomal subunit as a control displayed similar band densities in all of the stages tested (data not shown). Real-time PCR showed that cardiac β2 integrin mRNA levels increase in the AV canal during the remodeling of endocardial cushion EMT and subsequent remodeling of the valves ( Figure 5 ). Real-time PCR controls with 18s showed equal levels in all stages (data not shown).
In situ hybridization protocols were performed on whole mounts and sections of chicken embryos to define the spatial distribution of β2 integrin mRNA transcripts during endocardial cushion EMT and AV valve remodeling. At HH14, β2 integrin was expressed in the cardiac myocardium and endocardium ( Figure 6A,C) . At HH20, β2 integrin mRNA was detected in a more pronounced manner in the myocardium, epicardium and endocardium, and was expressed in mesenchymal cells invading the endocardial cushions ( Figure 6B,D) . At HH25 and HH28, when the cushions are heavily populated by mesenchymal cells, β2 integrin continued to be detected clearly in the endothelial layer, Relative quantitation of β2 integrin expression in the chicken atrioventricular (AV) canal. mRNA was isolated from dissected AV canals at different stages of development and analyzed using real-time PCR. β2 integrin mRNA was detectable at stage HH14, increased significantly at HH17, during the period when numerous mesenchymal cells are actively migrating in the endocardial cushions, and progressively increased in subsequent stages. mRNA fold changes were calculated relative to the values obtained for HH14. Data are reported as means ± SEM for three experiments. Figure 6 . Localization of β2 integrin mRNA in chicken embryos using in situ hybridization. Positive labeling of β2 integrin mRNA was detected in whole mounts (A,B) and sections (C-F) of embryonic chicken hearts using an antisense riboprobe. A,C, HH14; B,D, HH20; E, HH25, and F, HH28. E (inset), Control in which HH25 showed no labeling with a sense probe for β2 integrin. At = atrium; M = myocardium; * = mesenchymal cells; arrows = heart; arrowheads = endothelium. Magnification bars = 100 µm. mesenchymal cells, epicardium, and myocardium ( Figure  6E,F) . Control sections hybridized with β2 integrin sense probe were negative ( Figure 6E, inset) .
Immunohistochemical studies using HRP-conjugated secondary antibodies were also performed in the developing chick. At HH14 β2 integrin staining was localized in the endothelium and the myocardium (Figure 7A,B) . At HH20, β2 integrin staining was more pronounced and was detected in endothelial layer, mesenchymal cells, epicardium, and myocardium ( Figure 7C,D) , matching the distribution pattern seen with in situ hybridization. As described by others (18) , β1 integrin was also present in the cardiac endothelium, myocardium and mesenchymal cells of the embryonic chicken heart (Figure 8 ). 
Discussion
The spatial and temporal distribution and multiple binding functions of integrins have been intensely studied since the earliest reports characterizing these matrix receptors appeared in the literature (1) . The fact that integrins play important roles in numerous cellular processes such as migration, adhesion, and signal transduction, as well as in morphogenesis and pathological process, continues to make them a focal point in research. A number of integrins have been characterized in the developing heart (18, 19) . The β2 integrin subfamily has been extensively studied, but most of this research centers on its role in the adhesion, migration and diapedesis of lymphocytes and leukocytes (6) . Although the β2 integrin family is frequently referred to as being "leukocyte specific" (10) , in the present study, using PCR, in situ hybridization, and immunohistochemical methods, we demonstrate that β2 integrin is also expressed by endothelial, mesenchymal, epicardial, and myocardial cells during normal heart development in both mammalian and avian embryos. It is noteworthy that three different alpha integrin partners for β2 integrin (i.e., αL, αM, and αX) were also detected during heart formation. The functional importance of each of these integrin α/β2 combinations during the process of cardiogenesis remains to be determined.
The functional role of β2 integrin has been studied in β2 integrin null mice (29) . These mice are viable and do not have any grossly obvious abnormalities in the heart or any other organs, but do display a phenotype closely resembling that of leukocyte adhesion deficiency type 1 patients, including leukocytosis, impaired leukocyte adhesion and migration, and the occurrence of mucocutaneous infections. However, it is important to note that in this study, the number of homozygous mice was lower than predicted by Mendelian genetics, suggesting that some β2 null offspring die prenatally. In addition, 10-40% of newborn β2 null animals were reported to die perinatally due to unreported causes. Previous studies have shown that β1, and possibly other β integrins, are able to compensate, at least partially, for the loss of β2 integrin (30) . Such compensatory mechanisms may allow some of the β2 null embryos to develop into adults. Other studies have shown that β2 null mice often have additional defects. For example, Miura et al. (13) reported that β2 null mice display certain features of osteoporosis, including decreased bone mineral density and increased trabecular bone space. Thus, based on the results presented here, a detailed morphometric analysis of the hearts of β2 null mice is warranted.
To our knowledge, there have been relatively few other studies demonstrating the presence of β2 integrin in developing tissues. The presence of high levels of β2 integrin mRNA was noted in the late tailbud stage of Xenopus embryos, but specific tissue distribution was not determined (16) . A study of ECM components and their integrin receptors in the human fetal adrenal gland demonstrated that β2 integrin is expressed by neural crest-derived chromaffin cells, which migrate through the fetal cortex on their way to the center of the gland, where they colonize and help form the medulla (15) . Whether β2 integrin is expressed by neural crest cells in other locations during development has not been reported. Several other studies have shown that β2 integrin is also expressed in cell types other than leukocytes, such as HUVEC and cancer cells (11, 12) . Although it is clear that a number of non-hematopoietic cells can express β2 integrin, little is known about the function of β2 integrin outside its leukocyte-associated activities.
The ligands, which bind to β2 integrin and its α partners in the embryonic heart, have not yet been determined. The β2/α heterodimers may interact with counter-receptors (eg., VCAM, ICAM) on adjacent cells and thus modulate cell-cell adhesion, or bind to ECM proteins. β2 integrins have been shown to bind to various ECM proteins, including collagens, fibronectin, fibrinogen, plasminogen, and heparin (2). Collagens, fibronectin and numerous other matrix proteins are present in most embryonic tissues, including the cardiac jelly (20, 21, (31) (32) (33) . Interestingly, β2 integrins also bind to CCN1 (CYR61), a secreted, cysteine-rich protein associated with the ECM that promotes cell adhesion, migration, proliferation, differentiation, and survival or death in a cell type-dependent manner (34) . CCN1 is expressed in the endothelium, cushion mesenchymal cells and myocardium, and is thought to be essential for tissue remodeling during cardiac development. Ccn1 null mice suffer embryonic lethality and display impaired cardiac valvuloseptal morphogenesis, which results in AVSDs (35) . Ccn1 deficiency does not affect endocardial cushion tissue formation or EMT, but results in accelerated apoptosis in cushion tissue and reduced gelatinous activity in the ventricular septum and AV valves.
The expression of β2 integrin within the embryonic heart during the period when the AV valves are still forming is especially relevant when one considers that the gene for β2 integrin is localized in the region of chromosome 21 associated with congenital heart defects (24) . Approximately 40% of trisomy 21/Down syndrome patients have congenital heart defects, the majority of which involve AVSDs. It is known that leukocytes and thymocytes from Down syndrome patients overexpress β2 integrin, which may affect immune defense in these patients (36) . The effect an increase in β2 integrin expression would have within the developing heart is unknown. When expressed at low levels in cell lines, β2 integrin cooperates with β1 integrins to support cell migration (37) . Conversely, increased expression of β2 integrin results in increased cell adhesiveness and inhibition of cell migration. In this system, β2 integrin appears to act as a brake: the higher the level of expression, the stronger the brake becomes until migration is finally stopped. It will be of interest to determine if β2 integrin functions in a similar manner in the embryonic heart. Many of the observations cited above support the idea that β2 integrin is functioning during the migration of the cushion tissue mesenchyme, but it is important to remember that β2 integrin is also expressed in the epicardium and myocardium during heart development. Additional studies will be needed in order to clarify the functional importance of β2 integrin in each of these locations during cardiac morphogenesis.
